OA Admission Exam study materials
OA Admission Exam study resources

Managing Acute Angle-Closure Glaucoma in a Patient with Multiple Systemic Conditions

OA Admission Exam · Put your knowledge to work in context.

All case studies

Managing Acute Angle-Closure Glaucoma in a Patient with Multiple Systemic Conditions

A 72-year-old woman presents with severe right eye pain, headache, nausea, and blurred vision. She has a history of hypertension, type 2 diabetes, and chronic obstructive pulmonary disease (COPD). She is on hydrochlorothiazide, metformin, and tiotropium. On examination, visual acuity is 20/200 OD and 20/40 OS. IOP is 48 mmHg OD and 16 mmHg OS. The right eye shows corneal edema, a mid-dilated pupil, and shallow anterior chamber. Gonioscopy reveals a closed angle. She is diagnosed with acute angle-closure glaucoma (AACG).

1. What are the immediate management steps for AACG, considering her systemic conditions?

Read the worked answer

Immediate management aims to lower IOP and relieve the angle closure. Start with topical beta-blocker (e.g., timolol) and alpha-agonist (e.g., apraclonidine), and systemic carbonic anhydrase inhibitor (acetazolamide 500 mg IV). Avoid topical pilocarpine initially because it may worsen the condition by causing miosis and increased iris-lens contact; however, once IOP starts to decrease, pilocarpine can be used. Hyperosmotic agents (mannitol) may be used if IOP remains high, but caution in diabetes and hypertension. Avoid anticholinergic effects of tiotropium? Tiotropium is an anticholinergic and may precipitate AACG, but it is inhaled and systemic absorption is low; however, consider alternative if possible. Definitive treatment is laser peripheral iridotomy (LPI) once the cornea clears. If LPI cannot be performed, surgical iridectomy. Also, control blood pressure and glucose.

2. How would you modify the treatment plan given her COPD and diabetes?

Read the worked answer

In COPD, avoid systemic beta-blockers (e.g., oral timolol) as they can cause bronchospasm. Topical beta-blockers are generally safe but use with caution; consider selective beta-1 blockers if available. Acetazolamide can cause metabolic acidosis, which may worsen COPD; monitor. Hyperosmotic agents like mannitol can cause hyperglycemia and volume overload, so use with caution in diabetes and hypertension. Pilocarpine may cause bronchospasm; use cautiously. LPI is safe. Also, consider that tiotropium may have anticholinergic effects but inhaled; however, if possible, consult with pulmonologist to switch to a non-anticholinergic bronchodilator. Monitor blood glucose closely.